Associations of self-reported cigarette smoking with chronic obstructive pulmonary disease and co-morbid chronic conditions in the United States

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 3, 2015, Pages 281-291

  Cunningham, Timothy J ^a   Ford, Earl S ^a   Rolle, Italia V ^a   Wheaton, Anne G ^a   Croft, Janet B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Chronic disease; COPD; Cross sectional studies; Smoking; Tobacco use

Indexed keywords

CHOLESTEROL;

ADULT; AGE; AGED; ARTHRITIS; ARTICLE; ASTHMA; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HEALTH INSURANCE; HUMAN; HYPERTENSION; INCOME; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; NEOPLASM; PREVALENCE; PRIORITY JOURNAL; RACE; SELF REPORT; SEX DIFFERENCE; SMOKING; UNITED STATES; YOUNG ADULT; ADOLESCENT; CORONARY DISEASE; HYPERCHOLESTEROLEMIA; KIDNEY DISEASES; NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STROKE;

ADOLESCENT; ADULT; AGED; ARTHRITIS; ASTHMA; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; COMORBIDITY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF REPORT; SMOKING; STROKE; UNITED STATES; YOUNG ADULT;

EID: 84933529059     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.949001     Document Type: Article

References (25)

1. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD Surveillance-United States, 1999-2011. Chest 2013 Jul 1; 144(1):284-305.
2. Barr RG, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba FC, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Ame J Med 2009 Apr; 122(4):348-355.
3. Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respir Inter Rev Th orac Dis 2010; 80(2):112-119.
4. Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulmon Med 2011 Dec; 17 Suppl 1:S21-28.
5. Corsonello A, Pedone C, Incalzi RA. Comorbidities and risk assessment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012 Oct 15; 186(8):804; author reply 5.
6. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B, BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012 Jul 15; 186(2):155-161.
7. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Euro Respir J 1997 Dec; 10(12):2794-2800.
8. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Euro Respir J 2008 Oct; 32(4):962-969.
9. Putcha N, Puhan MA, Hansel NN, Drummond MB, Boyd CM. Impact of co-morbidities on self-rated health in self-reported COPD: An analysis of NHANES 2001-2008. COPD 2013 Jun; 10(3):324-332.
10. Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd C. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulmon Med 2012; 12:26.
11. van Manen JG, Bindels PJ, CJ IJ, van der Zee JS, Bottema BJ, Schade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001 Mar; 54(3):287-293.
12. Vanfleteren LEGW, Spruit MA, Groenen M, Gaffron S, van Empel VPM, Bruijnzeel PLB, et al. Clusters of comorbidities based on validated objective measurements and systemic infl ammation in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care 2013 Apr 1; 187(7):728-735.
13. US Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. 2010. Available from: http://www.surgeongeneral. gov/library/reports/tobaccosmoke/full-report.pdf (accessed 9 August 2013).
14. Centers for Disease Control and Prevention. Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential Effects on prevalence estimates. MMWR Morbid Mortal Week Rept 2012 Jun 8; 61(22):410-413.
15. Fahimi M, Link M, Mokdad A, Schwartz DA, Levy P. Tracking chronic disease and risk behavior prevalence as survey participation declines: statistics from the behavioral risk factor surveillance system and other national surveys. Prevent Chron Dis 2008 Jul; 5(3):A80.
16. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System, 2011 Summary Data Quality Report. In: editor. Centers for Disease Control and Prevention, Atlanta, GA.
17. Goodman RA, Posner SF, Huang ES, Parekh AK, Koh HK. Defi ning and measuring chronic conditions: imperatives for research, policy, program, and practice. Prevent Chron Dis 2013; 10:E66.
18. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 statistical notes: From the Centers for Disease Control and Prevention/National Center for Health Statistics 2001 Jan; 20:1-10.
19. Kleinman LC, Norton EC. What's the Risk A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression. Health Serv Res 2009 Feb; 44(1):288-302.
20. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. 2014. Available from: http://www. surgeongeneral.gov/initiatives/tobacco (accessed 9 January 2014).
21. Centers for Disease Control and Prevention. Smokingattributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morbid Mortal Week Rept2008 Nov 14; 57(45):1226-1228.
22. Centers for Disease Control and Prevention. Best practices for comprehensive tobacco control programs-2014. Atlanta, GA: US Department of Health and Human Services; 2014. Available from: http://www.cdc.gov/tobacco/stateandcommunity/best-practices/index.htm (accessed 18 June 2014).
23. Wagena EJ, van Amelsvoort LG, Kant I, Wouters EF. Chronic bronchitis, cigarette smoking, and the subsequent onset of depression and anxiety: results from a prospective populationbased cohort study. Psychosom Med 2005 Jul-Aug; 67(4):656-660.
24. Bauer CM, Morissette MC, Stampfli MR. The infl uence of cigarette smoking on viral infections: translating bench science to impact COPD pathogenesis and acute exacerbations of COPD clinically. Chest 2013 Jan; 143(1):196-206.
25. Szklo M, Nieto FJ. Epidemiology: Beyond the Basics, 2nd ed. Sudbury, Mass.: Jones and Bartlett Publishers, 2007; 117-118.